Carregant...
Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B
BACKGROUND: Partial or an entire deletion of SHANK3 are considered as major drivers in the Phelan–McDermid syndrome, in which 75% of patients are diagnosed with autism spectrum disorder (ASD). During the recent years, there was an increasing interest in stem cell therapy in ASD, and specifically, me...
Guardat en:
| Publicat a: | Mol Autism |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7433169/ https://ncbi.nlm.nih.gov/pubmed/32807217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13229-020-00366-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|